CELLULAR THERAPY: 0078-0846

Brand Name: KYMRIAH

Generic Name: tisagenlecleucel

Primary Class: CD19 Receptor Interactions [MoA]

SPL Set ID: aad3ba54-dfd3-4cb3-9e2b-c5ef89559189 view on Dailymed | RXCUI: 1986442

Manufacturer Name: Novartis Pharmaceuticals Corporation

Associated Package NDCs
Package NDC Description
0078-0846-19 1 INJECTION, SUSPENSION in 1 BAG (0078-0846-19)